ReviewDrugs1997
Management of patients with acute ischaemic stroke.
Review in Drugs, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 19 citations in OpenAlex.
- A Review on Neuroinflammatory Pathway Mediating Through Ang-II/AT1 Receptors and a Novel Approach for the Treatment of Cerebral Ischemia in Combination with ARB's and Ceftriaxone.Annals of neurosciences · 2024Review
- Drug treatment of acute ischemic stroke.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2013Review
Corrections and comments
- Erratum issued
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The management of patients with acute ischaemic stroke, which was once accompanied by a sense of futility, has shifted to emergency intervention, as a result of clinical trials demonstrating the efficacy of acutely administered therapies in reducing mortality and morbidity. The current approach to stroke thus emphasises early recognition, rapid transport to hospital, speedy evaluation and urgent treatment. In the emergency room, treatment decisions are largely influenced by the neurological status of patients, although their respiratory, cardiovascular and metabolic status are also considered. Initially, efforts are aimed at reducing hypoxia and hypercarbia, controlling symptoms such as pain or vomiting, and reducing the morbidity and mortality associated with stroke. Most patients with stroke require hospitalisation; in-hospital care continues to focus on preventing and controlling subacute and chronic complications, but also includes planning for rehabilitation and care after discharge, and treatment to prevent recurrent stroke. Administration of newer treatment interventions, such as thrombolytic therapy, requires the availability of teams of stroke specialists; furthermore, the management of stroke patients in a dedicated unit has been shown to reduce death and disability and to shorten the hospital stay. While therapies aimed at reducing the neurological consequences of stroke are the keystone of current and future care, the control of acute, subacute, or chronic medical and neurological complications, prevention of recurrent stroke, and rehabilitation to maximise recovery from stroke remain crucial components of patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.